{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:43:47Z","timestamp":1794609827736,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-021-00172-1","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:22:21Z","timestamp":1613578941000},"page":"357-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors"],"prefix":"10.1038","volume":"2","author":[{"given":"Elise M.","family":"Fiala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtham","family":"Jayakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-5651","authenticated-orcid":false,"given":"Yelena","family":"Kemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan Harlan","family":"Fleischut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Salo-Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela G.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Latham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-7408","authenticated-orcid":false,"given":"Maria I.","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cadoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semanti","family":"Murkherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Slotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Trippett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Glade Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-6101","authenticated-orcid":false,"given":"Paul A.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filemon S.","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-5171","authenticated-orcid":false,"given":"Nai-Kong","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kentsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine H.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Khakoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gilheeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Farouk Sait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-6528","authenticated-orcid":false,"given":"Matthias","family":"Karajannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel","family":"Modak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T.","family":"Gerstle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Jairam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-151X","authenticated-orcid":false,"given":"Joseph","family":"Vijai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-4471","authenticated-orcid":false,"given":"Sabine","family":"Topka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia K.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3109-1692","authenticated-orcid":false,"given":"Mark","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-5000","authenticated-orcid":false,"given":"Michael F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Ceyhan-Birsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4517-0751","authenticated-orcid":false,"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mandelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerav N.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-4104","authenticated-orcid":false,"given":"Ahmet","family":"Zehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-6778","authenticated-orcid":false,"given":"Michael F.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"172_CR1","unstructured":"Howlader, N. et al. (eds.) SEER Cancer Statistics Review, 1975\u20132014 (National Cancer Institute, 2017)."},{"key":"172_CR2","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","volume":"373","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 373, 2336\u20132346 (2015).","journal-title":"N. Engl. J. Med."},{"key":"172_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jama.2015.10080","volume":"314","author":"RJ Mody","year":"2015","unstructured":"Mody, R. J. et al. Integrative clinical sequencing in the management of refractory or relapsed cancer in youth. JAMA 314, 913\u2013925 (2015).","journal-title":"JAMA"},{"key":"172_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1001\/jamaoncol.2015.5689","volume":"2","author":"MH Harris","year":"2016","unstructured":"Harris, M. H. et al. Multicenter feasibility study of tumor molecular profiling to inform therapeutic decisions in advanced pediatric solid tumors: the individualized cancer therapy (iCat) study. JAMA Oncol. 2, 608\u2013615 (2016).","journal-title":"JAMA Oncol."},{"key":"172_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0389-6","volume":"8","author":"JA Oberg","year":"2016","unstructured":"Oberg, J. A. et al. Implementation of next generation sequencing into pediatric hematology\u2013oncology practice: moving beyond actionable alterations. Genome Med. 8, 133 (2016).","journal-title":"Genome Med."},{"key":"172_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jamaoncol.2015.5699","volume":"2","author":"DW Parsons","year":"2016","unstructured":"Parsons, D. W. et al. Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol. 2, 616\u2013624 (2016).","journal-title":"JAMA Oncol."},{"key":"172_CR7","doi-asserted-by":"crossref","unstructured":"Wong, M. et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat. Med. 26, 1742\u20131753 (2020).","DOI":"10.1038\/s41591-020-1072-4"},{"key":"172_CR8","unstructured":"Walsh, M. et al. in Abeloff\u2019s Clinical Oncology 6th edn (eds Niederhuber, J. E. et al.) Ch. 13 (Elsevier, 2020)."},{"key":"172_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet. 45, 242\u2013252 (2013).","journal-title":"Nat. Genet."},{"key":"172_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10897-017-0077-8","volume":"26","author":"S Scollon","year":"2017","unstructured":"Scollon, S. et al. A comprehensive review of pediatric tumors and associated cancer predisposition syndromes. J. Genet. Couns. 26, 387\u2013434 (2017).","journal-title":"J. Genet. Couns."},{"key":"172_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jmedgenet-2018-105664","volume":"56","author":"M Suerink","year":"2019","unstructured":"Suerink, M. et al. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy. J. Med. Genet. 56, 53\u201362 (2019).","journal-title":"J. Med. Genet."},{"key":"172_CR12","doi-asserted-by":"crossref","unstructured":"Gault, M. D. et al. Germline SDHA mutations in children and adults with cancer. Cold Spring Harb. Mol. Case Stud. 4, a002584 (2018).","DOI":"10.1101\/mcs.a002584"},{"key":"172_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00744-3","volume":"12","author":"N Oak","year":"2020","unstructured":"Oak, N. et al. Ancestry-specific predisposing germline variants in cancer. Genome Med. 12, 51 (2020).","journal-title":"Genome Med"},{"key":"172_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41591-020-0982-5","volume":"26","author":"JJ Grzymski","year":"2020","unstructured":"Grzymski, J. J. et al. Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Nat. Med. 26, 1235\u20131239 (2020).","journal-title":"Nat. Med."},{"key":"172_CR15","doi-asserted-by":"crossref","unstructured":"Walsh, M.F. et al. Germline BRCA2 mutations detected in pediatric sequencing studies impact parents\u2019 evaluation and care. Cold Spring Harb. Mol. Case Stud. 3, a001925 (2017).","DOI":"10.1101\/mcs.a001925"},{"key":"172_CR16","doi-asserted-by":"crossref","unstructured":"Offit, K. et al. Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening. J. Clin. Oncol. 38, 1398\u20131408 (2020).","DOI":"10.1200\/JCO.19.02010"},{"key":"172_CR17","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"172_CR18","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","volume":"379","author":"K Moore","year":"2018","unstructured":"Moore, K. et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N. Engl. J. Med. 379, 2495\u20132505 (2018).","journal-title":"N. Engl. J. Med."},{"key":"172_CR19","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","volume":"34","author":"E Bouffet","year":"2016","unstructured":"Bouffet, E. et al. Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J. Clin. Oncol. 34, 2206\u20132211 (2016).","journal-title":"J. Clin. Oncol."},{"key":"172_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","volume":"382","author":"AM Gross","year":"2020","unstructured":"Gross, A. M. et al. Selumetinib in children with inoperable plexiform neurofibromas. N. Engl. J. Med. 382, 1430\u20131442 (2020).","journal-title":"N. Engl. J. Med."},{"key":"172_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro, J. et al. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 20, 1011\u20131022 (2019).","journal-title":"Lancet Oncol."},{"key":"172_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.18632\/oncotarget.362","volume":"2","author":"DG van Vuurden","year":"2011","unstructured":"van Vuurden, D. G. et al. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget 2, 984\u2013996 (2011).","journal-title":"Oncotarget"},{"key":"172_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2017.11137","volume":"318","author":"D Mandelker","year":"2017","unstructured":"Mandelker, D. et al. Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA 318, 825\u2013835 (2017).","journal-title":"JAMA"},{"key":"172_CR24","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/humu.23640","volume":"39","author":"MF Walsh","year":"2018","unstructured":"Walsh, M. F. et al. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes. Hum. Mutat. 39, 1542\u20131552 (2018).","journal-title":"Hum. Mutat."},{"key":"172_CR25","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz, C. P. et al. Cancer screening recommendations for individuals with Li\u2013Fraumeni syndrome. Clin. Cancer Res. 23, e38\u2013e45 (2017).","journal-title":"Clin. Cancer Res."},{"key":"172_CR26","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam, S. P. et al. Von Hippel\u2013Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin. Cancer Res. 23, e68\u2013e75 (2017).","journal-title":"Clin. Cancer Res."},{"key":"172_CR27","doi-asserted-by":"crossref","unstructured":"Fiala, E. M. et al. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood. Cancer 126, 3114\u20133121 (2020).","DOI":"10.1002\/cncr.32907"},{"key":"172_CR28","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","volume":"25","author":"R Benayed","year":"2019","unstructured":"Benayed, R. et al. High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden. Clin. Cancer Res. 25, 4712\u20134722 (2019).","journal-title":"Clin. Cancer Res."},{"key":"172_CR29","doi-asserted-by":"publisher","first-page":"e1913900","DOI":"10.1001\/jamanetworkopen.2019.13900","volume":"2","author":"R Karam","year":"2019","unstructured":"Karam, R. et al. Assessment of diagnostic outcomes of RNA genetic testing for hereditary cancer. JAMA Netw. Open 2, e1913900 (2019).","journal-title":"JAMA Netw. Open"},{"key":"172_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pbc.23283","volume":"58","author":"S Knapke","year":"2012","unstructured":"Knapke, S. et al. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr. Blood Cancer 58, 85\u201389 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"172_CR31","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamaoncol.2020.0197","volume":"6","author":"L Mirabello","year":"2020","unstructured":"Mirabello, L. et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol. 6, 724\u2013734 (2020).","journal-title":"JAMA Oncol."},{"key":"172_CR32","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1200\/JCO.19.02760","volume":"38","author":"N Qin","year":"2020","unstructured":"Qin, N. et al. Pathogenic germline mutations in DNA repair genes in combination with cancer treatment exposures and risk of subsequent neoplasms among long-term survivors of childhood cancer. J. Clin. Oncol. 38, 2728\u20132740 (2020).","journal-title":"J. Clin. Oncol."},{"key":"172_CR33","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.cgh.2013.04.044","volume":"11","author":"RN Sharaf","year":"2013","unstructured":"Sharaf, R. N. et al. Uptake of genetic testing by relatives of Lynch syndrome probands: a systematic review. Clin. Gastroenterol. Hepatol. 11, 1093\u20131100 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"172_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41525-019-0096-5","volume":"4","author":"E Courtney","year":"2019","unstructured":"Courtney, E. et al. Impact of free cancer predisposition cascade genetic testing on uptake in Singapore. NPJ Genom. Med. 4, 22 (2019).","journal-title":"NPJ Genom. Med."},{"key":"172_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.19.02005","volume":"38","author":"MK Frey","year":"2020","unstructured":"Frey, M. K. et al. Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling. J. Clin. Oncol. 38, 1389\u20131397 (2020).","journal-title":"J. Clin. Oncol."},{"key":"172_CR36","doi-asserted-by":"crossref","unstructured":"Srinivasan, S. et al. Stakeholder perspectives on overcoming barriers to cascade testing in Lynch syndrome: a qualitative study. Cancer Prev. Res. 13, 1037\u20131046 (2020).","DOI":"10.1158\/1940-6207.CAPR-20-0141"},{"key":"172_CR37","doi-asserted-by":"publisher","first-page":"e27629","DOI":"10.1002\/pbc.27629","volume":"66","author":"CR Tak","year":"2019","unstructured":"Tak, C. R. et al. Cost-effectiveness of early cancer surveillance for patients with Li\u2013Fraumeni syndrome. Pediatr. Blood Cancer 66, e27629 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"172_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng, D. T. et al. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251\u2013264 (2015).","journal-title":"J. Mol. Diagn."},{"key":"172_CR39","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703\u2013713 (2017).","journal-title":"Nat. Med."},{"key":"172_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-017-0271-4","volume":"10","author":"DT Cheng","year":"2017","unstructured":"Cheng, D. T. et al. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. BMC Med. Genomics 10, 33 (2017).","journal-title":"BMC Med. Genomics"},{"key":"172_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"172_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","volume":"13","author":"N Tung","year":"2016","unstructured":"Tung, N. et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat. Rev. Clin. Oncol. 13, 581\u2013588 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"172_CR43","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"172_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","volume":"571","author":"P Jonsson","year":"2019","unstructured":"Jonsson, P. et al. Tumour lineage shapes BRCA-mediated phenotypes. Nature 571, 576\u2013579 (2019).","journal-title":"Nature"},{"key":"172_CR45","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu, B. et al. MSIsensor: microsatellite instability detection using paired tumor\u2013normal sequence data. Bioinformatics 30, 1015\u20131016 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00172-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:22:38Z","timestamp":1733955758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1038\/s43018-021-00172-1","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.A.M.: Takeda, uncompensated speaking; Amgen, stock ownership; Ipsen, mock ODAC panel; Salarius, mock ODAC panel; P.A.M.\u2019s spouse: Boehringer Ingelheim, consulting; Genentech, speakers\u2019 bureau; Eastern Pulmonary Society. N.K.C. holds ownership interest\/equity in Y-mAbs Therapeutics, Inc., reports receiving commercial research grants from Y-mAbs Therapeutics, Inc., and Abpro Labs, Inc., holding ownership interest\/equity in Abpro Labs and owning stock options in Eureka Therapeutics, Inc. N.K.C. is a scientific advisory board member of Abpro Labs and Eureka Therapeutics. N.K.C. is the inventor and owner of issued patents licensed by MSK to Y-mAbs Therapeutics, Biotec Pharmacon and Abpro Labs. I.J.D. has done consulting and advisory board activities with Apexigen, AstraZeneca, Bayer, Bristol-Myers Squibb\/Celgene, Fennec and Roche. I.J.D. has served as an institutional PI for pharma-sponsored clinical trials at MSKCC from Bristol-Myers Squibb, Genentech and Novartis. M.K. has consultant agreements with AstraZeneca, Bayer, CereXis, QED Therapeutics and Recursion Pharma (personal fees received). S. Modak. is a consultant to Y-mAbs Therapeutics, Inc., Illumina, Inc., and Progenics Pharmaceuticals. Z.K.S.\u2019s immediate family member serves as a consultant for Allergan, Adverum Biotechnologies, Alimera Sciences, Fortress Biotech, Genentech\/Roche, Novartis, Optos, Regeneron, Regenxbio and Spark Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}